Lars Linden
Inventor
Stats
- 7 US patents issued
- 27 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 7 US Patents Issued
- 27 US Applications Filed
- 218 Total Citation Count
- Jan 21, 2022 Most Recent Filing
- Mar 10, 2000 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| SEATTLE GENETICS, INC. | 4
1 1 1 | 2012
2014 2015 2016 |
| BAYER INTELLECTUAL PROPERTY GMBH | 1
7 2 1 | 2010
2012 2016 2017 |
| UNWIRED PLANET, LLC | 1
| 2000
|
| HUBNER GMBH | 2
| 2003
|
| BAYER PHARMA AKTIENGESELLSCHAFT | 2
| 2014
|
| M-Phasys GmbH | 1
1 | 2003
2006 |
| DELLCRON AB | 2
| 2011
|
| TELEFONAKTIEBOLAGET L M ERICSSON (PUBL) | 3
| 2000
|
Inventor Addresses
| Address | Duration |
|---|---|
| DE | Apr 18, 13 - Apr 18, 13 |
| Berlin, DE | May 16, 13 - May 16, 13 |
| Düsseldorf, DE | Jul 03, 14 - Oct 03, 17 |
| Duesseldorf, DE | Sep 03, 15 - Sep 03, 15 |
| Dusseldorf, DE | Dec 20, 12 - Nov 03, 16 |
| Gavle, SE | Nov 07, 13 - Dec 05, 13 |
| Gevelsberg, DE | Jan 14, 16 - May 12, 22 |
| Hästveda, SE | Oct 25, 05 - Oct 25, 05 |
| Hastveda, SE | Oct 18, 01 - Apr 20, 04 |
| Horby, SE | Oct 09, 03 - Sep 21, 04 |
| Tuebingen, DE | Jun 16, 05 - Feb 08, 07 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 16 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 2 |
| B23D: | PLANING; SLOTTING; SHEARING; BROACHING; SAWING; FILING; SCRAPING; LIKE OPERATIONS FOR WORKING METAL BY REMOVING MATERIAL, NOT OTHERWISE PROVIDED FOR | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2022/0143,229 | 2022 | RADIO-PHARMACEUTICAL COMPLEXES | 0 |
| 11260136 | 2022 | Radio-pharmaceutical complexes | 0 |
| 2019/0091,354 | 2019 | RADIO-PHARMACEUTICAL COMPLEXES | 0 |
| 2018/0326,053 | 2018 | EPITOPE OF OPTIMIZED HUMANIZED MONOCLONAL ANTIBODIES AGAINST ACTIVATED PROTEIN C AND USES THEREOF | 0 |
| 9777063 | 2017 | Neutralizing prolactin receptor antibody Mat3 and its therapeutic use | 2 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.